BriaCell’s Bria-IMT™ combination regimen with immune checkpoint inhibitors activated cancer-fighting CD8+ T cells turning “Cold” tumors “Hot” on ImmunoPET imaging Advanced protein array technologies ...
WALTHAM, Mass. and BOULDER, Colo., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...
At this year’s AACR 2025 (Chicago, IL, USA; 25–30 April), the annual meeting of the American Association for Cancer Research, we picked out our favourite posters from the conference and spoke to their ...
Sweeney won the Top Presentation Award for his talk titled, “The SUMO Balancing Act: Insights into Cellular Robustness from ...
The Chosun Ilbo on MSN
KAIST unveils B-cell targeting AI cancer vaccine
The fear of cancer stems from the dread that it can recur at any time, even after treatment. A South Korean research team has ...
Scientists have discovered that bacteria living inside tumors can produce a molecule that fights cancer and enhances chemotherapy. The molecule, called 2-methylisocitrate (2-MiCit), was found to make ...
Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body Illustration of a human cancer cell Amber Dance, Knowable Magazine Back in ...
Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers than our primate cousins. The change affects a protein used by immune cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback